4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial

2009 ◽  
Vol 7 (2) ◽  
pp. 216 ◽  
Author(s):  
F. Rivera ◽  
C. Gravalos ◽  
B. Massutí ◽  
J. Puente ◽  
E. Marcuello ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patients ◽  
Advanced Colorectal Cancer ◽  
Final Analysis ◽  
Cooperative Group ◽  
Line Treatment ◽  
First Line ◽  
Kras Status ◽  
Group Trial ◽  
First Line Treatment

scholarly journals Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

2010 ◽  
Vol 102 (10) ◽  
pp. 1468-1473 ◽  
Author(s):  
J Feliu ◽  
M J Safont ◽  
A Salud ◽  
F Losa ◽  
C García-Girón ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patients ◽  
Metastatic Colorectal Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals First-line treatment with modified FOLFOXIRI plus bevacizumab in patients with locally advanced colorectal cancer

2020 ◽  
Vol 28 (1) ◽  
pp. 44-48 ◽  
Author(s):  
Yasufumi Yamada ◽  
Kazuhiko Yoshimatsu ◽  
Hajime Yokomizo ◽  
Sachiyo Okayama ◽  
Hiroyuki Maeda ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Advanced Colorectal Cancer ◽  
Locally Advanced ◽  
Line Treatment ◽  
First Line ◽  
Locally Advanced Colorectal Cancer ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document